Empagliflozin for Breast Cancer
(EMBRACE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The primary objective of this pilot study is to evaluate the feasibility and acceptability of a clinical trial protocol investigating 10 mg/day empagliflozin in breast cancer patients receiving anthracycline-based chemotherapy.
Who Is on the Research Team?
Elisa Palladino, Ph.D
Principal Investigator
Virginia Commonwealth University
Are You a Good Fit for This Trial?
This trial is for people with breast cancer who are about to start anthracycline-based chemotherapy. Participants should be able to safely take empagliflozin and follow the study procedures.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Empagliflozin
Trial Overview
The study is testing if taking 10 mg of empagliflozin daily is practical and acceptable for breast cancer patients during their chemotherapy. It focuses on how well patients can stick to this added medication.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Empagliflozin 10 mg oral tablet
Find a Clinic Near You
Who Is Running the Clinical Trial?
Virginia Commonwealth University
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.